Action Research on Land Management in the Western Amazon, Peru – A Research Process, Its Outcomes and the Researcher’s Role

The article explores the action research process throughout a land management research project, with the ambition to reflect upon action research as a working approach. It is shown how this process is experienced from a researcher’s point of view and it critically analyses its methodology and process, outcome and the role of the action researcher.The learning environment known to farmers and framed by local institutions and practical experimentation, embedded in the local worldview, constituted a necessary starting point for achieving motivation and practical outcomes. Tight feedback loops between practice and reflection enabled joint learning and innovation and rapid implementation of measures suggested by the farmers. The approach could be particularly useful for local NGOs and local universities.     

Microorganism-associated variation in host infestation efficiency in a parasitoid wasp,Trichogramma bourarachae (Hymenoptera: Trichogrammatidae)

InTrichogramma bourarachae (Hymenoptera: Trichogrammatidae), the infestation efficiency presents important variation among strains: 60 eggs/5 days/female in the High (H) strain and 25 eggs/5 days/female in the Low (L) strain. Crosses show that between-strains variation is inherited by the matrocline route. Antibiotic and heat treatments reduce infestation efficiency in the H strain and have no effect on the L strain. The hypothesis of cytoplasmic-symbiotic microorganisms accounting for the higher infestation efficiency in the H strain is supported by microscopic observations. The origin and the significance of this between-strains variation are discussed.     

Human hepatitis B vaccine from recombinant yeast

The worldwide importance of human hepatitis B virus infection and the toll it takes in chronic liver disease, cirrhosis and hepatocarcinoma, make it imperative that a vaccine be developed for worldwide application. Human hepatitis B vaccines are presently prepared using hepatitis B surface antigen (HBsAg) that is purified from the plasma of human carriers of hepatitis B virus infection. The preparation of hepatitis B vaccine from a human source is restricted by the available supply of infected human plasma and by the need to apply stringent processes that purify the antigen and render it free of infectious hepatitis B virus and other possible living agents that might be present in the plasma. Joint efforts between our laboratories and those of Drs W. Rutter and B. Hall led to the preparation of vectors carrying the DNA sequence for HBsAg and antigen expression in the yeast Saccharomyces cerevisiae. Here we describe the development of hepatitis B vaccine of yeast cell origin. HBsAg of subtype adw was produced in recombinant yeast cell culture, and the purified antigen in alum formulation stimulated production of antibody in mice, grivet monkeys and chimpanzees. Vaccinated chimpanzees were totally protected when challenged intravenously with either homologous or heterologous subtype adr and ayw virus of human serum source. This is the first example of a vaccine produced from recombinant cells which is effective against a human viral infection.     

Effect of biogenic amines on γ-amylase (acid α-glucosidase)

, , - . .